Statistics for A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

Total visits

views
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder. 40

Total visits per month

views
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0

File Visits

views
Cusin_Perlis-2013_Double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.pdf 199